471 related articles for article (PubMed ID: 24760246)
1. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
[TBL] [Abstract][Full Text] [Related]
2. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
3. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
[TBL] [Abstract][Full Text] [Related]
4. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
5. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers for bone turnover predict risk of vertebral fractures in postmenopausal women over 10 years: the Japanese Population-based Osteoporosis (JPOS) Cohort Study.
Tamaki J; Iki M; Kadowaki E; Sato Y; Chiba Y; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
Osteoporos Int; 2013 Mar; 24(3):887-97. PubMed ID: 22885773
[TBL] [Abstract][Full Text] [Related]
7. Vertebral fracture in postmenopausal Chinese women: a population-based study.
Cui L; Chen L; Xia W; Jiang Y; Cui L; Huang W; Wang W; Wang X; Pei Y; Zheng X; Wang Q; Ning Z; Li M; Wang O; Xing X; Lin Q; Yu W; Weng X; Xu L; Cummings SR
Osteoporos Int; 2017 Sep; 28(9):2583-2590. PubMed ID: 28560474
[TBL] [Abstract][Full Text] [Related]
8. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
Kanazawa I; Notsu M; Miyake H; Tanaka K; Sugimoto T
Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
Shigdel R; Osima M; Ahmed LA; Joakimsen RM; Eriksen EF; Zebaze R; Bjørnerem Å
Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
[TBL] [Abstract][Full Text] [Related]
10. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
Nguyen LT; Nguyen UDT; Nguyen TDT; Ho-Pham LT; Nguyen TV
Osteoporos Int; 2018 Dec; 29(12):2739-2744. PubMed ID: 30196375
[TBL] [Abstract][Full Text] [Related]
11. Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.
Bruyère O; Collette J; Rizzoli R; Decock C; Ortolani S; Cormier C; Detilleux J; Reginster JY
Osteoporos Int; 2010 Jun; 21(6):1031-6. PubMed ID: 19813043
[TBL] [Abstract][Full Text] [Related]
12. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
Shetty S; John B; Mohan S; Paul TV
Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of serum total P1NP, β-CTX and 25(OH)D3 detection in evaluating risks of fragile hip fracture in elderly patients with osteoporosis].
Lou H; Peng C; Chen Q
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1346-9. PubMed ID: 22985580
[TBL] [Abstract][Full Text] [Related]
14. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
[TBL] [Abstract][Full Text] [Related]
15. Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.
Zhao C; Liu G; Zhang Y; Xu G; Yi X; Liang J; Yang Y; Liang J; Ma C; Ye Y; Yu M; Qu X
J Clin Lab Anal; 2020 Apr; 34(4):e23112. PubMed ID: 31733013
[TBL] [Abstract][Full Text] [Related]
16. Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus.
Liu XX; Jiang L; Liu Q; Zhang J; Niu W; Liu J; Zhang Q
J Diabetes Res; 2020; 2020():6191468. PubMed ID: 32851096
[TBL] [Abstract][Full Text] [Related]
17. Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate.
Brown JP; Roux C; Ho PR; Bolognese MA; Hall J; Bone HG; Bonnick S; van den Bergh JP; Ferreira I; Dakin P; Wagman RB; Recknor C
Osteoporos Int; 2014 Jul; 25(7):1953-61. PubMed ID: 24676847
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial.
Binkley N; Bone H; Gilligan JP; Krause DS
Osteoporos Int; 2014 Nov; 25(11):2649-56. PubMed ID: 25027109
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a normal reference value of parathyroid hormone in a large healthy Chinese population and evaluation of its relation to bone turnover and bone mineral density.
Li M; Lv F; Zhang Z; Deng W; Li Y; Deng Z; Jiang Y; Wang O; Xing X; Xu L; Xia W
Osteoporos Int; 2016 May; 27(5):1907-16. PubMed ID: 26733373
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
